Revenue Analysis - MYGN
Comprehensive quarterly and annual revenue breakdown by product lines and geographic regions to identify growth drivers and market opportunities.
MYGN Corporation
Revenue by Product Line
Latest quarterly revenue breakdown by product segments
Quarterly Product Revenue
Product Revenue Details
Detailed breakdown of revenue by product line
Molecular Diagnostic Testing
0.0% of total revenue
$167.3M
Molecular Diagnostic Hereditary Cancer Testing
0.0% of total revenue
$79.4M
Molecular Diagnostic Prenatal Testing
0.0% of total revenue
$23.6M
Molecular Diagnostic Other Testing
0.0% of total revenue
$0
Pharmaceutical And Clinical Services
0.0% of total revenue
$0
Historical Revenue Data
Quarterly product revenue breakdown over time (Last 6 records)
| Date | Molecular Diagnostic Endo Predict Testing | Molecular Diagnostic Genesight Testing | Molecular Diagnostic Hereditary Cancer Testing | Molecular Diagnostic Other Testing | Molecular Diagnostic Prenatal Testing | Molecular Diagnostic Prolaris Testing | Molecular Diagnostic Testing | Molecular Diagnostic Vectra Testing | Pharmaceutical And Clinical Services |
|---|---|---|---|---|---|---|---|---|---|
| 9/30/2021 | $0 | $0 | $79.4M | $0 | $23.6M | $0 | $167.3M | $0 | $0 |
| 6/30/2021 | $0 | $0 | $86.0M | $1.3M | $29.4M | $0 | $178.7M | $0 | $10.7M |
| 3/31/2021 | $4.1M | $17.6M | $76.1M | $500.0K | $23.7M | $18.5M | $159.6M | $10.7M | $13.5M |
Revenue Trend Analysis
Analysis of major growing and declining segments based on recent revenue data
Product Segments
Declining Segments
Geographic Regions
Stable Segments
Earnings Reports
Want to see how MYGN's earnings relate to revenue? View quarterly earnings results, EPS history, and earnings surprises to understand the company's profitability.
View Earnings Reports